Instruction for use: Oxycort

Active substance Hydrocortisone + Oxytetracycline

ATX code D07CA01 Hydrocortisone in combination with antibiotics

Pharmacological group

Glucocorticosteroids in combinations

Nosological classification (ICD-10)

A46 erysipelas

Erysipelas

L00-L08 Infections of the skin and subcutaneous tissue

L01 Impetigo

Bullous impetigo, Vulgar impetigo, Simple contact dermatitis complicated by impetigo, Contagious impetigo, Ordinary impetigo, Streptococcal impetigo

L02 Skin abscess, furuncle and carbuncle

Furuncle of external auditory canal, Furuncle of the auricle, Furuncles, Abscess, Abscess of skin, Carbuncle, Carbuncle skin, Furuncle, Skin furuncle, Furunculosis, Chronic recurrent furunculosis

L10 Pemphigus [pemphigus]

Benign pemphigoid of mucous membranes, Bubble dermatosis, Pemphigus, Dermatitis, vesicular, Benign pemphigus, Ordinary pemphigus, Pemphigus, Bubble dermatitis, Family benign pemphigus Hailey-Hailey

L20 Atopic dermatitis

Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis

L25 Contact dermatitis, unspecified

Intertriginous dermatitis, Contact Eczema, Contact dermatitis, Contact dermatitis of non-microbial etiology, Contact dermatitis, Skin wetting surface, Fractures, Intertrigo,Skin Difficulty, Subacute and chronic contact dermatitis, Phlebotoderma, Simple contact dermatitis complicated by impetigo

L26 Exfoliative dermatitis

Dermatitis exfoliative, Exfoliative dermatitis generalized

L28 Simple chronic lichen and prurigo

Scab, Prurigo, Bacterial prurigo, Limited prurigo with a strong lichenization, Nodular pruritis

L30.3 Infectious dermatitis

Microbial skin infections, Dermatitis with concomitant bacterial infections, Dermatitis in the presence of a bacterial infection or suspected of it, Infected eczema of external auditory canal, Secondarily infected dermatosis, Erythema migrans, Secondarily infected dermatoses , Dermatitis re-infected, Infectious dermatitis, Dermatitis infected, Dermatoses complicated by a secondary infection, Dermatoses complicated by primary and secondary infection, Dermatoses complicated by primary and / or secondary infection, Infected eczema, Infected dermatitis, Infected dermatosis, Migrating erythema, Microbial eczema, Chronic migratory erythema, Eczema is infected, Erythema Migrating, Bacterial dermatitis, Erythema migratory chronic, Superinfectant dermatitis, Necrolytic Migrating erythema

L30.4 Erythematous intertrigo

Erythema of the buttocks, Dermatitis traumatic, Intertrigo, Interdigital intertrigo

L73.2 Hyperadenitis purulent

Hydradenite, Bony udders

L73.8.0 * Sycosis

Sycosis of the beard

L73.8.1 * Folliculitis

Superficial folliculitis, Folliculitis

Composition and form of release

Ointment 1 g

Oxytetracycline hydrochloride 30 mg

Hydrocortisone acetate 10 mg

Base components: petrolatum white

In tubes of 10 g; In a pack of cardboard 1 tuba.

pharmachologic effect

Pharmacological action - anti-inflammatory, antibacterial, antiallergic, antipruritic.

Oppresses phospholipase A2, reduces synthesis of PG (prostaglandins) and other biologically active substances (hydrocortisone), disrupts the binding of transport RNA (ribonucleic acid) and ribosomal membrane in microbial cells, inhibits protein synthesis, causing a bacteriostatic effect (oxytetracycline).

Pharmacodynamics

It alters the structure and reduces the permeability of tissue and cell membranes, reduces the migration of macrophages and lymphocytes, affects all phases of inflammation, blocks the release of sensitized mast cells and basophils histamine and other biologically active substances. Effective in the treatment of allergic and inflammatory skin diseases, complicated by a secondary bacterial infection.

Indications

Chronic pyoderma (streptococcal, staphylococcal, mixed); Chronic purulent complications of allergic skin diseases; Allergic dermatitis, eczema, pruritis (including children's), contact dermatitis, impetigo (vulgar, bullous), bacterial diaper rash, furuncles, furunculosis, multiple abscesses, urticaria, insect bites.

Contraindications

Hypersensitivity, viral skin diseases (herpes, chicken pox), skin tuberculosis, fungal skin diseases, neoplasms and precancerous skin conditions.

pregnancy and lactation

It is not recommended for pregnancy, especially for long-term use and in large areas of the skin. For the duration of treatment, breastfeeding should be stopped.

Side effects

Skin irritation at the site of application (especially in case of allergy to the components of the drug); Secondary infections caused by fungi or resistant to oxytetracycline by microorganisms; When applied to the skin of the face - telangiectasia, atrophy of subcutaneous tissue in the mouth.

Dosing and Administration

Outwardly. Apply a thin layer on the affected skin 2-3 times a day (sometimes apply a bandage, applying ointment on sterile gauze). The course of treatment - 1-2 weeks. Children (especially up to 2 years) are used in limited areas of the skin with a short course (for 5-7 days).

Precautionary measures

If it is necessary to apply on the face skin, treatment should be short (increased absorption and the possibility of side effects).

Storage conditions

At a temperature not higher than 25 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.